Skip to main content

Chalazion

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Lumenis
LumenisAustralia - Chatswood
2 programs
OptiLIGHTN/A1 trial
Sham IPLN/A1 trial
Active Trials
NCT07039461Terminated4Est. Dec 2025
NCT07405138Not Yet Recruiting40Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2025
2026
LumenisSham IPL
LumenisOptiLIGHT

Clinical Trials (2)

Total enrollment: 44 patients across 2 trials

Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

Start: Feb 2026Est. completion: Dec 202640 patients
N/ANot Yet Recruiting

Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

Start: Sep 2025Est. completion: Dec 20254 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.